Two Sigma Securities’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-18,391
Closed -$8.13K 3574
2023
Q1
$8.13K Sell
18,391
-19,047
-51% -$7.46K ﹤0.01% 2484
2022
Q4
$8.22K Buy
37,438
+14,353
+62% +$4.29K ﹤0.01% 2392
2022
Q3
$8K Sell
23,085
-22,961
-50% -$15.7K ﹤0.01% 2439
2022
Q2
$30K Buy
+46,046
New +$30.6K ﹤0.01% 1910
2022
Q1
Sell
-35,905
Closed -$41K 2710
2021
Q4
$41K Buy
+35,905
New +$73.1K ﹤0.01% 1309

Other funds holding CEMI

Two Sigma Securities's CEMI Position: Q2 2023 in Review

Two Sigma Securities sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 18,391 shares — an estimated $8.13K sold.

Two Sigma Securities first reported a position in CEMI in Q4 2021 and held it in 5 quarters. The position peaked at $41K in Q4 2021. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.

  • Two Sigma Securities reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Securities sold 18,391 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $8.13K.
  • Two Sigma Securities first reported a position in Chembio diagnostics, Inc. in Q4 2021 and held it in 5 quarters.
  • Two Sigma Securities's Chembio diagnostics, Inc. position peaked at $41K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.

Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.